‘We Can’t Keep Going On Like This’ – Biosimilars Forum’s Reed Calls For Urgent Changes In US
FDA Processes Need Overhaul, Insists Forum’s Executive Director
Julie Reed says the time has come for key changes in the US biosimilars sector (Shutterstock) 
